Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VTI vs GSK✓SelectedUSD · GSKVTI vs GSK performance historyLatest closeAs of-0.41%11/13
Stock and ETF performance explorer

VTI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+77.4%
GSK return
+65.8%
Excess return
+11.6%
Maximum drawdown
-19.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%+0.5%-0.9%-0.5%
7D+2.5%+1.1%+1.4%+2.4%
30D-1.5%+6.3%-7.9%-2.1%
3M-3.2%+1.8%-5.0%-3.4%
6M+2.3%+1.7%+0.7%+2.0%
YTD+11.6%+6.5%+5.1%+10.7%
1Y+13.8%+9.5%+4.3%+12.5%
3Y+77.4%+65.3%+12.1%+68.7%
All+77.4%+65.8%+11.6%+68.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling